Steris | STE - Interest Expense On Debt


Steris reported $14.9M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
3M USD 214M 18M Mar/2026
Accuray USD 2.88M 72K Dec/2024
Avanos Medical USD 1.9M 100K Dec/2025
Baxter International USD 58M 14M Sep/2025
Becton, Dickinson and Co. USD 149M 4M Mar/2026
Boston Scientific USD 90M 0 Mar/2026
CONMED USD 7.06M 310K Mar/2026
Cooper Companies USD 22.4M 2M Dec/2025
Dexcom USD 4.2M 500K Dec/2025
Ecolab USD 82.9M 27.6M Dec/2025
Edwards Lifesciences USD 35.9M 2.7M Dec/2025
Fortive USD 31.6M 600K Mar/2026
Getinge SEK 164M 1000K Dec/2025
Globus Medical USD 5.44B 5.44B Mar/2026
Haemonetics USD 7.4M 190K Dec/2025
Idexx Laboratories USD 7.74M 2.34M Mar/2026
Inogen 1.03M 384K Mar/2025
Insulet USD 14.7M 5.5M Mar/2026
Integra LifeSciences USD 22.46M 1.21M Mar/2026
Intuitive Surgical USD 20.11B 58.39B Mar/2026
J&J USD 43M 25M Mar/2026
Masimo USD 6.1M 1.4M Mar/2026
Olympus JPY 516M 1.83B Mar/2026
Orthofix International 4.68M 731K Sep/2025
Owens Minor USD 27.93M 1.1M Dec/2025
ResMed USD 8.79M 14.55M Sep/2025
Steris USD 14.9M 0 Dec/2025
Stryker USD 46.29B 45.68B Mar/2026
Tandem Diabetes Care USD 1.15B 1.15B Mar/2026
Teleflex USD 25.72M 2.43M Mar/2026
Thermo Fisher Scientific USD 354M 11M Mar/2026
Zimmer Biomet Holdings USD 68.8M 3.1M Mar/2026